{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:56:03Z","timestamp":1773456963404,"version":"3.50.1"},"reference-count":44,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIMSN"],"published-print":{"date-parts":[[2021]]},"abstract":"<abstract>\n<p>Lesch-Nyhan disease (LND) is a rare X-linked inherited neurogenetic disorders of purine metabolic in which the cytoplasmic enzyme, hypoxanthine-guanine phosphoribosyltransferase (HGprt) is defective. Despite having been characterized over 60 years ago, however, up to now, there is no satisfactory explanation of how deficits in enzyme HGprt can lead to LND with the development of the persistent and severe self-injurious behavior. Recently, a role for epistasis between the mutated hypoxanthine phosphoribosyltransferase 1 (<italic>HPRT1<\/italic>) and the \u03b2-amyloid precursor protein (APP) genes affecting the regulation of alternative APP pre-mRNA splicing in LND has been demonstrated. Furthermore, there were also some reported cases of LND developing thrombosis while APP is an important regulator of vein thrombosis and controls coagulation. Otherwise, the surface expression of HGprt enzyme was also observed in several somatic tissue cancers while APP and the APP-like protein-2 (APLP2) are deregulated in cancer cells and linked to increased tumor cell proliferation, migration, and invasion. The present review provides a discussion about these findings and suggests a potential molecular link between APP and HGprt via epistasis between <italic>HPRT1<\/italic> and <italic>APP<\/italic> genes affecting the regulation of alternative APP pre-mRNA splicing. As a perspective, expression vectors for HGprt enzyme and APP are constructed as described in Ref. # 24 (Nguyen KV, Naviaux RK, Nyhan WL (2020) Lesch-Nyhan disease: I. Construction of expression vectors for hypoxanthine-guanine phosphoribosyltransferase (HGprt) enzyme and amyloid precursor protein (APP). <italic>Nucleosides Nucleotides Nucleic Acids<\/italic> 39: 905\u2013922), and they could be used as tools for clarification of these issues. In addition, these expression vectors, especially the one with the glycosyl-phosphatidylinositol (GPI) anchor can be used as a model for the construction of expression vectors for any protein targeting to the cell plasma membrane for studying intermolecular interactions and could be therefore useful in the vaccines as well as antiviral drugs development (studying intermolecular interactions between the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, as well as its variants and the angiotensin-converting enzyme 2, ACE2, in coronavirus disease 2019 (COVID-19) <xref ref-type=\"bibr\" rid=\"b43\">[43]<\/xref>,<xref ref-type=\"bibr\" rid=\"b44\">[44]<\/xref>, for example).<\/p>\n<\/abstract><\/jats:p>","DOI":"10.3934\/neuroscience.2021030","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T04:44:33Z","timestamp":1635396273000},"page":"548-557","source":"Crossref","is-referenced-by-count":6,"title":["Potential molecular link between the \u03b2-amyloid precursor protein (APP) and hypoxanthine-guanine phosphoribosyltransferase (HGprt) enzyme in Lesch-Nyhan disease and cancer"],"prefix":"10.3934","volume":"8","author":[{"given":"Khue Vu","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Former Institution Attended:","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Medicine, Biochemical Genetics and Metabolism, The Mitochondrial and Metabolic Disease Center, School of Medicine, University of California, San Diego, Building CTF, Room C-103, 214 Dickinson Street, San Diego, CA 92103-8467, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Pediatrics, University of California, San Diego, School of Medicine, San Diego, La Jolla, CA 92093-0830, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2321","reference":[{"key":"key-10.3934\/Neuroscience.2021030-1","doi-asserted-by":"crossref","unstructured":"Stout JT, Caskey CT (1985) HPRT: gene structure, expression, and mutation. Ann Rev Genet<\/i> 19: 127-148.","DOI":"10.1146\/annurev.ge.19.120185.001015"},{"key":"key-10.3934\/Neuroscience.2021030-2","doi-asserted-by":"crossref","unstructured":"Patel PI, Framson PE, Caskey CT, et al. (1986) Fine structure of the human hypoxanthine phosphoribosyl transferase gene. Mol Cell Biol<\/i> 6: 396-403.","DOI":"10.1128\/MCB.6.2.393"},{"key":"key-10.3934\/Neuroscience.2021030-3","doi-asserted-by":"crossref","unstructured":"Lesch M, Nyhan WL (1964) A familial disorder of uric acid metabolism and central nervous system function. Am J Med<\/i> 36: 561-570.","DOI":"10.1016\/0002-9343(64)90104-4"},{"key":"key-10.3934\/Neuroscience.2021030-4","doi-asserted-by":"crossref","unstructured":"Seegmiller JE, Rosenbloom FM, Kelley WN (1967) Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science<\/i> 155: 1682-1684.","DOI":"10.1126\/science.155.3770.1682"},{"key":"key-10.3934\/Neuroscience.2021030-5","unstructured":"Morton NE, Lalouel JM (1977) Genetic epidemiology of Lesch-Nyhan disease. Am J Hum Genet<\/i> 29: 304-311."},{"key":"key-10.3934\/Neuroscience.2021030-6","doi-asserted-by":"crossref","unstructured":"Fu R, Ceballos-Picot I, Torres RJ, et al. (2014) For the Lesch-Nyhan disease international study group. Genotype-phenotype correlation in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain<\/i> 137: 1282-1303.","DOI":"10.1093\/brain\/awt202"},{"key":"key-10.3934\/Neuroscience.2021030-7","doi-asserted-by":"crossref","unstructured":"Micheli V, Bertelli M, Jacomelli G, et al. (2018) Lesch-Nyhan disease: a rare disorder with many unresolved aspects. Medical University<\/i> 1: 13-24.","DOI":"10.2478\/medu-2018-0002"},{"key":"key-10.3934\/Neuroscience.2021030-8","doi-asserted-by":"crossref","unstructured":"Nguyen KV (2014) Epigenetic regulation in amyloid precursor protein and the Lesch-Nyhan syndrome. Biochem Biophys Res Commun<\/i> 446: 1091-1095.","DOI":"10.1016\/j.bbrc.2014.03.062"},{"key":"key-10.3934\/Neuroscience.2021030-9","doi-asserted-by":"crossref","unstructured":"Nguyen KV (2015) Epigenetic regulation in amyloid precursor protein with genomic rearrangements and the Lesch-Nyhan syndrome. Nucleosides Nucleotides Nucleic Acids<\/i> 34: 674-690.","DOI":"10.1080\/15257770.2015.1071844"},{"key":"key-10.3934\/Neuroscience.2021030-10","doi-asserted-by":"crossref","unstructured":"Nguyen KV, Nyhan WL (2017) Quantification of various APP-mRNA isoforms and epistasis in Lesch-Nyhan disease. Neurosci Lett<\/i> 643: 52-58.","DOI":"10.1016\/j.neulet.2017.02.016"},{"key":"key-10.3934\/Neuroscience.2021030-11","doi-asserted-by":"crossref","unstructured":"Imamura A, Yamanouchi H, Kurokawa T (1992) Elevated fibrinopeptide A (FPA) in patients with Lech-Nyhan syndrome. Brain Dev<\/i> 14: 424-425.","DOI":"10.1016\/S0387-7604(12)80355-X"},{"key":"key-10.3934\/Neuroscience.2021030-12","doi-asserted-by":"crossref","unstructured":"Riaz IB, Husnain M, Ateeli H (2014) Recurrent thrombosis in a patient with Lesch-Nyhan syndrome. Am J Med<\/i> 127: e11-e12.","DOI":"10.1016\/j.amjmed.2014.01.033"},{"key":"key-10.3934\/Neuroscience.2021030-13","doi-asserted-by":"crossref","unstructured":"Tewari N, Mathur VP, Sardana D, et al. (2017) Lesch-Nyhan syndrome: the saga of metabolic abnormality and self-injurious behavior. Intractable Rare Dis Res<\/i> 6: 65-68.","DOI":"10.5582\/irdr.2016.01076"},{"key":"key-10.3934\/Neuroscience.2021030-14","doi-asserted-by":"crossref","unstructured":"Canobbio I, Visconte C, Momi S, et al. (2017) Platelet amyloid precursor protein is a modulator of venous thromboembolism in mice. Blood<\/i> 130: 527-536.","DOI":"10.1182\/blood-2017-01-764910"},{"key":"key-10.3934\/Neuroscience.2021030-15","doi-asserted-by":"crossref","unstructured":"Townsend MH, Anderson MD, Weagel EG, et al. (2017) Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane. Onco Targets Ther<\/i> 10: 1921-1932.","DOI":"10.2147\/OTT.S128416"},{"key":"key-10.3934\/Neuroscience.2021030-16","doi-asserted-by":"crossref","unstructured":"Weagel EG, Townsend MH, Anderson MD, et al. (2017) Abstract 2149: Unusual expression of HPRT on the surface of the colorectal cancer cell lines HT29 and SW620. Cancer Res<\/i> 77: 2149. American Association for Cancer Research Cited 22 May 2018. Available from: (http:\/\/cancerres.aacrjournals.org\/lookup\/doi\/10.1158\/1538-7445.AM2017-2149<\/a>).","DOI":"10.1158\/1538-7445.AM2017-2149"},{"key":"key-10.3934\/Neuroscience.2021030-17","doi-asserted-by":"crossref","unstructured":"Townsend MH, Felsted AM, Ence ZE, et al. (2017) Elevated expression of hypoxanthine guanine phosphoribosyltransferase within malignant tissue. Cancer Clin Oncol<\/i> 6: 19.","DOI":"10.5539\/cco.v6n2p19"},{"key":"key-10.3934\/Neuroscience.2021030-18","doi-asserted-by":"crossref","unstructured":"Townsend MH, Felsted AM, Burrup W, et al. (2018) Examination of hypoxanthine guanine phosphoribosyltransferase as a biomarker for colorectal cancer patients. Mol Cell Oncol<\/i> 5: e1481810.","DOI":"10.1080\/23723556.2018.1481810"},{"key":"key-10.3934\/Neuroscience.2021030-19","doi-asserted-by":"crossref","unstructured":"Townsend MH, Robison RA, O'Neill KL (2018) A review of HPRT and its emerging role in cancer. Med Oncol<\/i> 35: 89(https:\/\/doi.org\/10.1007\/s12032-018-1144-1<\/a>).","DOI":"10.1007\/s12032-018-1144-1"},{"key":"key-10.3934\/Neuroscience.2021030-20","doi-asserted-by":"crossref","unstructured":"Townsend MH, Shrestha G, Robison RA, et al. (2018) The expansion of targetable biomarkers for CAR T cell therapy. J Exp Clin Cancer Res<\/i> 37: 163.","DOI":"10.1186\/s13046-018-0817-0"},{"key":"key-10.3934\/Neuroscience.2021030-21","doi-asserted-by":"crossref","unstructured":"Townsend MH, Ence ZE, Felsted AM, et al. (2019) Potential new biomarkers for endometrial cancer. Cancer Cell Int<\/i> 19: 19.","DOI":"10.1186\/s12935-019-0731-3"},{"key":"key-10.3934\/Neuroscience.2021030-22","doi-asserted-by":"crossref","unstructured":"Pandey P, Sliker B, Peters HL, et al. (2016) Amyloid precursor protein and amyloid precursor-like protein 2 in cancer. Oncotarget<\/i> 7: 19430-19444.","DOI":"10.18632\/oncotarget.7103"},{"key":"key-10.3934\/Neuroscience.2021030-23","doi-asserted-by":"crossref","unstructured":"Nguyen KV (2019) \u03b2-Amyloid precursor protein (APP) and the human diseases. AIMS Neurosci<\/i> 6: 273-281.","DOI":"10.3934\/Neuroscience.2019.4.273"},{"key":"key-10.3934\/Neuroscience.2021030-24","doi-asserted-by":"crossref","unstructured":"Nguyen KV, Naviaux RK, Nyhan WL (2020) Lesch-Nyhan disease: I. Construction of expression vectors for hypoxanthine-guanine phosphoribosyltransferase (HGprt) enzyme and amyloid precursor protein (APP). Nucleosides Nucleotides Nucleic Acids<\/i> 39: 905-922.","DOI":"10.1080\/15257770.2020.1714653"},{"key":"key-10.3934\/Neuroscience.2021030-25","doi-asserted-by":"crossref","unstructured":"Gottle M, Prudente CN, Fu R, et al. (2014) Loss of dopamine phenotype among midbrain neurone in Lesch-Nyhan disease. Ann Neurol<\/i> 76: 95-107.","DOI":"10.1002\/ana.24191"},{"key":"key-10.3934\/Neuroscience.2021030-26","doi-asserted-by":"crossref","unstructured":"Ceballos-Picot I, Mockel L, Potier MC, et al. (2009) Hypoxanthine-guanine phosphoribosyltransferase regulates early development programming of dopamine neurons: implication for Lesch-Nyhan disease pathogenesis. Hum Mol Genet<\/i> 18: 2317-2327.","DOI":"10.1093\/hmg\/ddp164"},{"key":"key-10.3934\/Neuroscience.2021030-27","doi-asserted-by":"crossref","unstructured":"Connolly GP, Duley JA, Stacey NC (2001) Abnormal development of hypoxanthine-guanine phosphoribosyltransferase-deficient CNS neuroblastoma. Brain Res<\/i> 918: 20-27.","DOI":"10.1016\/S0006-8993(01)02909-2"},{"key":"key-10.3934\/Neuroscience.2021030-28","doi-asserted-by":"crossref","unstructured":"Stacey NC, Ma MHY, Duley JA, et al. (2000) Abnormalities in cellular adhesion of neuroblastoma and fibroblast models of Lesch-Nyhan syndrome. Neuroscience<\/i> 98: 397-401.","DOI":"10.1016\/S0306-4522(00)00149-4"},{"key":"key-10.3934\/Neuroscience.2021030-29","doi-asserted-by":"crossref","unstructured":"Harris JC, Lee RR, Jinnah HA, et al. (1998) Craniocerebral magnetic resonance imaging measurement and findings in Lesch-Nyhan syndrome. Arch Neurol<\/i> 55: 547-553.","DOI":"10.1001\/archneur.55.4.547"},{"key":"key-10.3934\/Neuroscience.2021030-30","doi-asserted-by":"crossref","unstructured":"Schretlen DJ, Varvaris M, Ho TE, et al. (2013) Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study. Lancet Neurol<\/i> 12: 1151-1158.","DOI":"10.1016\/S1474-4422(13)70238-2"},{"key":"key-10.3934\/Neuroscience.2021030-31","doi-asserted-by":"crossref","unstructured":"Schretlen DJ, Varvaris M, Tracy D, et al. (2015) Brain white matter volume abnormalities in Lesch-Nyhan disease and its variants. Neurology<\/i> 84: 190-196.","DOI":"10.1212\/WNL.0000000000001128"},{"key":"key-10.3934\/Neuroscience.2021030-32","doi-asserted-by":"crossref","unstructured":"Kang TH, Friedmann T (2015) Alzheimer's disease shares gene expression aberrations with purinergic dysregulation of HPRT deficiency (Lesch-Nyhan disease). Neurosci Lett<\/i> 590: 35-39.","DOI":"10.1016\/j.neulet.2015.01.042"},{"key":"key-10.3934\/Neuroscience.2021030-33","doi-asserted-by":"crossref","unstructured":"Tuner PR, O'Connor K, Tate WP, et al. (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol<\/i> 70: 1-32.","DOI":"10.1016\/S0301-0082(03)00089-3"},{"key":"key-10.3934\/Neuroscience.2021030-34","unstructured":"Zheng H, Koo EH (2006) The amyloid precursor protein: beyond amyloid. Mol Neurodegener<\/i> 1: 5."},{"key":"key-10.3934\/Neuroscience.2021030-35","doi-asserted-by":"crossref","unstructured":"Nguyen KV (2015) The human \u03b2-amyloid precursor protein: biomolecular and epigenetic aspects. Bio Mol Concepts<\/i> 6: 11-32.","DOI":"10.1515\/bmc-2014-0041"},{"key":"key-10.3934\/Neuroscience.2021030-36","doi-asserted-by":"crossref","unstructured":"Xu F, Previti ML, Nieman MT, et al. (2009) A\u03b2PP\/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis. J Neurosci<\/i> 29: 5666-5670.","DOI":"10.1523\/JNEUROSCI.0095-09.2009"},{"key":"key-10.3934\/Neuroscience.2021030-37","doi-asserted-by":"crossref","unstructured":"Xu F, Davis J, Hoos M, et al. (2017) Mutation of the Kunitz-type proteinase inhibitor domain in the amyloid \u03b2-protein precursor abolishes its anti-thrombotic properties in vivo<\/i>. Thromb Res<\/i> 155: 58-64.","DOI":"10.1016\/j.thromres.2017.05.003"},{"key":"key-10.3934\/Neuroscience.2021030-38","doi-asserted-by":"crossref","unstructured":"Di Luca M, Colciaghi F, Pastorino L, et al. (2000) Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein. Eur J Pharmacol<\/i> 405: 277-283.","DOI":"10.1016\/S0014-2999(00)00559-8"},{"key":"key-10.3934\/Neuroscience.2021030-39","doi-asserted-by":"crossref","unstructured":"Cordell HJ (2002) Epistasis: what it means, what it doesn't mean, and statistical method to detect it in humans. Hum Mol Genet<\/i> 11: 2463-2468.","DOI":"10.1093\/hmg\/11.20.2463"},{"key":"key-10.3934\/Neuroscience.2021030-40","doi-asserted-by":"crossref","unstructured":"Moore JH (2003) The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered<\/i> 56: 73-82.","DOI":"10.1159\/000073735"},{"key":"key-10.3934\/Neuroscience.2021030-41","doi-asserted-by":"crossref","unstructured":"Riordan JD, Nadeau JH (2017) From peas to disease: modifier genes, network resilience, and the genetics of health. Am J Hum Genet<\/i> 101: 177-191.","DOI":"10.1016\/j.ajhg.2017.06.004"},{"key":"key-10.3934\/Neuroscience.2021030-42","unstructured":"Saonere JA (2011) Antisense therapy, a magic bullet for the treatment of various diseases: present and future prospects. J Med Genet Genom<\/i> 3: 77-83."},{"key":"key-10.3934\/Neuroscience.2021030-43","doi-asserted-by":"crossref","unstructured":"Coutard B, Valle C, de Lamballerie X, et al. (2020) The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site in CoV of the same clade. Antiviral Res<\/i> 176: 104742.","DOI":"10.1016\/j.antiviral.2020.104742"},{"key":"key-10.3934\/Neuroscience.2021030-44","doi-asserted-by":"crossref","unstructured":"Nguyen KV (2021) Problems associated with antiviral drugs and vaccines development for COVID-19: approach to intervention using expression vectors via GPI anchor. Nucleosides Nucleotide Nucleic Acids<\/i> 40: 665-706.","DOI":"10.1080\/15257770.2021.1914851"}],"container-title":["AIMS Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/Neuroscience.2021030?viewType=html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T04:44:51Z","timestamp":1635396291000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/Neuroscience.2021030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3934\/neuroscience.2021030","relation":{},"ISSN":["2373-7972"],"issn-type":[{"value":"2373-7972","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}